ArticleCancer immunology research2022

PRDX-1 Supports the Survival and Antitumor Activity of Primary and CAR-Modified NK Cells under Oxidative Stress.

Marta Klopotowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.